These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 18316103)
1. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'. Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103 [TBL] [Abstract][Full Text] [Related]
2. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles. Ojikutu B; Jack C; Ramjee G J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705 [TBL] [Abstract][Full Text] [Related]
3. Universal access to antiretroviral therapy: when, not if. Carpenter CC Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338 [No Abstract] [Full Text] [Related]
4. Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV care. Rasson S; Boyer S; Fugon L; Protopopescu C; Marcellin F; Koulla-Shiro S; Kouanfack C; Spire B; Moatti JP; Carrieri MP; Antivir Ther; 2011; 16(3):423-8. PubMed ID: 21555826 [TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. Reid SE; Reid CA; Vermund SH Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453 [TBL] [Abstract][Full Text] [Related]
6. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R; Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046 [TBL] [Abstract][Full Text] [Related]
7. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007. Assefa Y; Kloos H Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406 [TBL] [Abstract][Full Text] [Related]
8. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi. Libamba E; Makombe S; Harries AD; Chimzizi R; Salaniponi FM; Schouten EJ; Mpazanje R Int J Tuberc Lung Dis; 2005 Oct; 9(10):1062-71. PubMed ID: 16229216 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa. Sellier P; Clevenbergh P; Ljubicic L; Simoneau G; Evans J; Delcey V; Diemer M; Bendenoun M; Mouly S; Bergmann JF Clin Infect Dis; 2006 Sep; 43(5):654-7. PubMed ID: 16886162 [TBL] [Abstract][Full Text] [Related]
10. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention? Menon S J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646 [TBL] [Abstract][Full Text] [Related]
11. Delivery of antiretroviral therapy in sub-saharan Africa. Weller I Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955 [No Abstract] [Full Text] [Related]
13. Innovations in access to TB and HIV/AIDS care in sub-Saharan Africa: dynamic engagement of the private sector. Montagu D; Elzinga G Appl Health Econ Health Policy; 2003; 2(4):175-80. PubMed ID: 15119536 [No Abstract] [Full Text] [Related]
14. Antiretroviral therapy in sub-Saharan Africa: myth or reality? Kebba A J Antimicrob Chemother; 2003 Nov; 52(5):747-9. PubMed ID: 14563895 [No Abstract] [Full Text] [Related]
15. Inequalities in health: access to treatment for HIV/AIDS. Giuliano M; Vella S Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264 [TBL] [Abstract][Full Text] [Related]
16. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875 [TBL] [Abstract][Full Text] [Related]
17. Combining prevention, treatment and care: lessons from South Africa. Achmat Z; Simcock J AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746 [TBL] [Abstract][Full Text] [Related]
18. [AIDS treatment in Africa: the risk of antiretroviral resistance]. Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083 [TBL] [Abstract][Full Text] [Related]
19. The (political) economics of antiretroviral treatment in developing countries. Nattrass NJ Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022 [TBL] [Abstract][Full Text] [Related]
20. Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Bemelmans M; Baert S; Goemaere E; Wilkinson L; Vandendyck M; van Cutsem G; Silva C; Perry S; Szumilin E; Gerstenhaber R; Kalenga L; Biot M; Ford N Trop Med Int Health; 2014 Aug; 19(8):968-77. PubMed ID: 24889337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]